Publications in collaboration with researchers from Hospital Universitario de la Princesa (71)


  1. PriME-PGX: La Princesa university hospital multidisciplinary initiative for the implementation of pharmacogenetics

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  2. Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

    Human Psychopharmacology, Vol. 36, Núm. 1, pp. 1-12

  3. Predictors of loss of functional independence in parkinson’s disease: Results from the coppadis cohort at 2-year follow-up and comparison with a control group

    Diagnostics, Vol. 11, Núm. 10

  4. Predictors of global non-motor symptoms burden progression in parkinson’s disease. Results from the coppadis cohort at 2-year follow-up

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  5. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

  6. Mood in Parkinson's disease: From early- to late-stage disease

    International journal of geriatric psychiatry, Vol. 36, Núm. 5, pp. 627-646

  7. Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics

    Advances in Therapy, Vol. 38, Núm. 2, pp. 1035-1054

  8. Influence of Genetic Polymorphisms on the Response to Tramadol, Ibuprofen, and the Combination in Patients With Moderate to Severe Pain After Dental Surgery

    Clinical Therapeutics, Vol. 43, Núm. 5, pp. e86-e102

  9. Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers

    Biomedicine and Pharmacotherapy, Vol. 133

  10. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

  11. High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects

    Frontiers in Pharmacology, Vol. 12

  12. Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling

    Clinical Pharmacokinetics, Vol. 60, Núm. 2, pp. 261-270

  13. Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin

    Frontiers in Pharmacology, Vol. 12

  14. Diplopia is frequent and associated with motor and non-motor severity in parkinson’s disease: Results from the COPPADIS cohort at 2-year follow-up

    Diagnostics, Vol. 11, Núm. 12